Cite
HARVARD Citation
Trümpelmann, S. et al. (2022). Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients. Clinical and translational science. 15 (7), pp. 1606-1612. [Online].